Navigator Outreach for Medicaid Enrollment

RM
Overseen ByRebecca Myerson, MPH, PhD
Age: Any Age
Sex: Any
Trial Phase: Academic
Sponsor: University of Wisconsin, Madison
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial examines how different types of outreach from navigators affect Medicaid enrollment in Wisconsin. Navigators assist individuals in renewing Medicaid coverage. The trial will test various outreach methods, such as text messages, phone calls, and postcards, to determine which is most effective. Medicaid recipients in Wisconsin who need to renew their coverage may find this trial suitable. Participants should speak English or Spanish and have a cell phone number. As an unphased trial, this study offers a unique opportunity to improve Medicaid renewal processes and potentially benefit the community.

Do I have to stop taking my current medications for this trial?

The trial protocol does not specify whether you need to stop taking your current medications. It seems unlikely, as the trial focuses on Medicaid enrollment, not medical treatment.

Will I have to stop taking my current medications?

The trial protocol does not specify whether you need to stop taking your current medications.

What prior data suggests that navigator outreach is safe for Medicaid enrollment?

Research has shown that receiving help from navigators is generally safe for participants. Although specific studies on safety are lacking, as this involves communication rather than medical procedures, using navigators for Medicaid enrollment has not been known to cause harm. For instance, in 2019, navigators assisted about 205,000 people without any reported safety issues, suggesting that the process is well-tolerated. Participants can expect to receive messages or calls to assist with Medicaid renewal, a common practice.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it explores innovative outreach methods to help people enroll in Medicaid. Unlike traditional enrollment processes, these approaches utilize technology like text messages and chatbots to connect with navigators, making the process more accessible and engaging. Some methods also include reminder messages and outbound calls, providing multiple touchpoints to ensure participants are well-informed and supported. This trial aims to find out which techniques are most effective in increasing Medicaid enrollment, potentially transforming how similar programs are conducted in the future.

What evidence suggests that navigator outreach is effective for Medicaid enrollment?

Research has shown that navigators can significantly ease the process of renewing Medicaid coverage. This trial will evaluate various outreach methods, such as text messages and postcards, to connect participants with navigators. Studies have found that pre-recorded calls can prevent coverage denial due to paperwork issues and increase renewal rates by about 1%. The navigator program educates people about Medicaid and guides them through the renewal process. By offering one-on-one assistance, navigators simplify the process, helping people understand their options and complete the necessary steps to maintain their coverage.56789

Who Is on the Research Team?

RM

Rebecca Myerson, MPH, PhD

Principal Investigator

UW-Madison School of Medicine and Public Health

Are You a Good Fit for This Trial?

This trial is for individuals in Wisconsin who are enrolled in fee-for-service Medicaid and need to renew their coverage. Participants must be on the lists provided by Wisconsin DHS to Covering Wisconsin, understand English or Spanish, and have a cellular phone number.

Inclusion Criteria

Included on the lists Wisconsin DHS provides to Covering Wisconsin of fee-for-service Medicaid beneficiaries who need to renew their Medicaid coverage

Exclusion Criteria

Lack a cellular phone number
I prefer communicating in a language other than English or Spanish.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Outreach Intervention

Participants receive various forms of outreach to assist with Medicaid renewal, including text messages, postcards, and outbound calls.

up to 1 year

Follow-up

Participants are monitored for the effectiveness of outreach strategies on Medicaid enrollment and renewal.

up to 1 year

What Are the Treatments Tested in This Trial?

Interventions

  • Outreach From Navigators
Trial Overview The study is testing how different types of outreach from navigators affect Medicaid enrollment rates. Navigators help with one-on-one assistance during the renewal process. People will be randomly assigned to receive various forms of this outreach.
How Is the Trial Designed?
10Treatment groups
Experimental Treatment
Group I: Outreach via Text Message Encouraging a Call to a Hotline for Assistance + a Reminder MessageExperimental Treatment1 Intervention
Group II: Outreach via Text Message Encouraging Text Reply To Connect with Navigators+ a Reminder MessageExperimental Treatment1 Intervention
Group III: Outreach via Text Message Encouraging Text Reply To Connect with Navigators + Outbound CallExperimental Treatment1 Intervention
Group IV: Outreach via Text Message Encouraging Text Reply To Connect with NavigatorsExperimental Treatment1 Intervention
Group V: Outreach via Text Message Encouraging Reply To Connect with Navigators + Reminder MessageExperimental Treatment1 Intervention
Group VI: Outreach via Text Message Encouraging Call to Hotline + Outbound CallExperimental Treatment1 Intervention
Group VII: Outreach via Text Message Encouraging Call to HotlineExperimental Treatment1 Intervention
Group VIII: Outreach via Postcard + Outbound CallExperimental Treatment1 Intervention
Group IX: Outreach via PostcardExperimental Treatment1 Intervention
Group X: Outreach Text Message Encouraging Call a Hotline for Assistance + Reminder MessageExperimental Treatment1 Intervention

Outreach From Navigators is already approved in United States for the following indications:

🇺🇸
Approved in United States as Navigator Outreach for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Wisconsin, Madison

Lead Sponsor

Trials
1,249
Recruited
3,255,000+

Covering Wisconsin

Collaborator

Trials
3
Recruited
649,000+

Published Research Related to This Trial

The creation of a student-led Medicaid Enrollment Team at the HOPES free clinic aimed to help citizens overcome barriers to enrolling in Medicaid after its expansion in Virginia.
The paper outlines effective steps taken by this program that can serve as a model for future Medicaid enrollment efforts, emphasizing the importance of comprehensive assistance in improving access to healthcare.
Developing a Sustainable Model for Medicaid Enrollment at the HOPES Free Clinic.Taylor-Fishwick, JS., Patel, P., Van de Graaf, M., et al.[2021]
In a study of 696 patients across 7 intensive care units, 15.5% experienced adverse drug events (ADEs), with a significant portion (70%) of these being nonpreventable adverse drug reactions (ADRs).
The research highlighted that most preventable ADEs stemmed from medication errors during the prescribing stage (71.1%), indicating a critical need for improved pharmacovigilance and error reporting practices to enhance drug safety.
Incidence of adverse drug events and medication errors in intensive care units: a prospective multicenter study.Benkirane, RR., Abouqal, R., Haimeur, CC., et al.[2022]
The implementation of the Patient Navigator Program for hospitalized heart failure patients led to a significant reduction in the 30-day all-cause readmission rate, dropping from 25.6% at the medical center to 17.6% with the program.
Patients who received targeted interventions from the Navigator Team, such as education and follow-up, experienced even lower readmission rates of 10.3% and 6.1%, respectively, highlighting the effectiveness of personalized care in improving patient outcomes.
Implementation of a Patient Navigator Program to Reduce 30-day Heart Failure Readmission Rate.Di Palo, KE., Patel, K., Assafin, M., et al.[2018]

Citations

The Impact of Outreach and Assistance from Navigators on ...Outreach using pre-recorded calls prevented denials due to procedural reasons and increased Medicaid renewal rates by 1.0 percentage point across the full study ...
INFORMATION GAPS AND HEALTH INSURANCE ...As noted above, two key goals of the navigator program were to inform consumers about affordability programs, including Medicaid, and to facilitate health ...
2024 Navigator Funding and Enrollment Data.All 1:1 assistance provided to consumers by Navigators, excluding QHP enrollments and Medicaid/CHIP enrollments or referrals. Assistance in this category ...
Survey of Health Insurance Marketplace Assister ProgramsNavigator refers to Assister Programs that contract directly with the U.S. Centers for Medicare & Medicaid Services (CMS) to provide free ...
Affordable Care Act navigator program boosted insurance ...“Our research showed that the navigator program impacted coverage among the same underserved communities that many navigator programs said, in ...
CMS Announcement on Federal Navigator Program FundingData show that for the 2019 plan year, Navigators provided post-enrollment assistance to approximately 205,000 consumers. Despite markedly ...
Medicaid Data and ReportsNew York State Medicaid Enrollment Data. Medicaid enrollment trends. Monthly view of NYS Medicaid enrollment by residential county.
June 2025 Medicaid & CHIP Enrollment Data HighlightsThese data reflect a range of indicators related to key Medicaid and CHIP application, eligibility, and enrollment processes. View the complete dataset on Data.
2022 Survey of ACA Marketplace Assister Programs and ...About half of Assister Programs (53%) said they have good working relationships with their state Medicaid agency and nearly 6 in 10 said they ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security